reported that serum IL-6 levels increased during treatment in all six patients with anti-PD-1-induced psoriasis and all seven patients with other irAEs, while IL-6 levels declined in five out of seven control patients without irAEs according to a multiplex assay (50). Here, IL6 is linked to psoriasis.